Leukomax Trademark Details

Leukomax was registered on Tuesday, January 9, 1990 and is currently owned by Sandoz Pharmaceuticals Corporation under the registration number 1576014 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 27 years ago on Monday, July 15, 1996, according to the United State Patent & Trademark Office
Word Mark Leukomax
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sandoz Pharmaceuticals Corporation of East Hanover, NJ

View all trademarks for Sandoz Pharmaceuticals Corporation
Other Trademarks for Sandoz Pharmaceuticals Corporation
Serial Number 73803282
Registration Number 1576014
Status Date Monday, July 15, 1996
Filing Date Monday, July 15, 1996
Registration Date Tuesday, January 9, 1990
Attorney Barry A. Solomon

Correspondent

BARRY A. SOLOMON
SANDOZ PHARMACEUTICALS CORPORATION
59 ROUTE 10
EAST HANOVER, NJ 07936

Case File Statements

Goods & Services Pharmaceutical Preparations Related to Blood Cell Production

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Monday, July 15, 1996
First Use Anywhere Thursday, December 15, 1988
First Use In Commerce Thursday, December 15, 1988
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.